Mammary gland-specific secretion of biologically active immunosuppressive agent cytotoxic-T-lymphocyte antigen 4 human immunoglobulin fusion protein (CTLA4Ig) in milk by transgenesis

Journal of Immunological Methods

Volumn 277, Issue 1-2, 2003, Pages 171-183

  Lui, Vincent C H ^a   Tam, Paul K H ^a   Leung, Michael Y K ^b   Lau, James Y B ^b   Chan, Jacqueline K Y ^a   Chan, Vera S F ^a   Dallman, Margaret ^c   Cheah, Kathryn S E ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CTLA4Ig; Immunosuppression; Milk; Transgenesis; Transplantation

Indexed keywords

BETA LACTOGLOBULIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 IMMUNOGLOBULIN; HYBRID PROTEIN; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOREACTOR; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENETIC TRANSFECTION; GRAFT SURVIVAL; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; LACTATION; MAMMARY GLAND; MILK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TRANSGENIC ANIMAL; TRANSGENICS; TRANSPLANTATION;

ANIMALIA; MUS MUSCULUS; OVIS ARIES;

EID: 0038546813     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00071-1     Document Type: Article

References (62)

1. Abrams J.R., Lebwohl M.G., Guzzo C.A., Jegasothy B.V., Goldfarb M.T., Goffe B.S., Menter A., Lowe N.J., Krueger G., Brown M.J., Weiner R.S., Birkhofer M.J., Warner G.L., Berry K.K., Linsley P.S., Krueger J.G., Ochs H.D., Kelley S.L., Kang S. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103:1999;1243.
2. Abrams J.R., Kelley S.L., Hayes E., Kikuchi T., Brown M.J., Kang S., Lebwohl M.G., Guzzo C.A., Jegasothy B.V., Linsley P.S., Krueger J.G. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J. Exp. Med. 192:2000;681.
3. Archibald A.L., McClenaghan M., Hornsey V., Simons J.P., Clark A.J. High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5178.
4. Betsch, D.F., 1995. Pharmaceutical Production from Transgenic Animals. Biotechnology Information Series. North Central Regional Extension Publication NCR #552, 1-3.
5. Bijvoet A.G., Kroos M.A., Pieper F.R., de Boer H.A., Reuser A.J., van der Ploeg A.T., Verbeet M.P. Expression of cDNA-encoded human acid alpha-glucosidase in milk of transgenic mice. Biochim. Biophys. Acta. 1308:1996;93-96.
6. Brem G., Hartl P., Besenfelder U., Wolf E., Zinovieva N., Pfaller R. Expression of synthetic cDNA sequences encoding human insulin-like growth factor-1 (IGF-1) in the mammary gland of transgenic rabbits. Gene. 149:1994;351.
7. Chen C.M., Wang C.H., Wu S.C., Lin C.C., Lin S.H., Cheng W.T. Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences. Transgenic Res. 11:2002;257-268.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156.
9. Clark A.J. Gene expression in the mammary glands of transgenic animals. Biochem. Soc. Symp. 63:1998;133.
10. Clark A.J. The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins. J. Mammary Gland Biol. Neoplasia. 3:1998;337.
11. Clark A.J., Ali S., Archibald A.L., Bessos H., Brown P., Harris S., McClenaghan M., Prowse C., Simons J.P., Whitelaw C.B. The molecular manipulation of milk composition. Genome. 31:1989;950.
12. Coulibaly S., Besenfelder U., Fleischmann M., Zinovieva N., Grossmann A., Wozny M., Bartke I., Togel M., Muller M., Brem G. Human nerve growth factor beta (hNGF-beta): mammary gland specific expression and production in transgenic rabbits. FEBS Lett. 444:1999;111.
13. Das R.C. Production of therapeutical proteins from transgenic animals. BioBussiness. 2001;60-64. (Feb.).
14. Devinoy E., Thepot D., Stinnakre M.G., Fontaine M.L., Grabowski H., Puissant C., Pavirani A., Houdebine L.M. High level production of human growth hormone in the milk of transgenic mice: the upstream region of the rabbit whey acidic protein (WAP) gene targets transgene expression to the mammary gland. Transgenic Res. 3:1994;79-89.
15. Ebert K.M., Selgrath J.P., DiTullio P., Denman J., Smith T.E., Memon M.A., Schindler J.E., Monastersky G.M., Vitale J.A., Gordon K. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression. Biotechnology (N.Y.). 9:1991;835.
16. Ebert K.M., DiTullio P., Barry C.A., Schindler J.E., Ayres S.L., Smith T.E., Pellerin L.J., Meade H.M., Denman J., Roberts B. Induction of human tissue plasminogen activator in the mammary gland of transgenic goats. Biotechnology (N.Y.). 12:1994;699.
17. Echizenya H., Yamashita K., Takehara M., Konishi K., Nomura M., Yanagida N., Kitagawa N., Kobayashi T., Furukawa H., Inobe M., Uede T., Todo S. Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats. Transplant. Proc. 33:2001;183.
18. Edmunds T., Van Patten S.M., Pollock J., Hanson E., Bernasconi R., Higgins E., Manavalan P., Ziomek C., Meade H., McPherson J.M., Cole E.S. Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. Blood. 91:1998;4561.
19. Feinberg A.P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal. Biochem. 137:1984;266.
20. Feng S., Quickel R.R., Hollister-Lock J., McLeod M., Bonner-Weir S., Mulligan R.C., Weir G.C. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig. Transplantation. 67:1999;1607.
21. Greenberg N.M., Anderson J.W., Hsueh A.J., Nishimori K., Reeves J.J., deAvila D.M., Ward D.N., Rosen J.M. Expression of biologically active heterodimeric bovine follicle-stimulating hormone in milk of transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 88:1991;8327-8331.
22. Guillot C., Mathieu P., Coathalem H., Le Mauff B., Castro M.G., Tesson L., Usal C., Laumonier T., Brouard S., Soulillou J.P., Lowenstein P.R., Cuturi M.C., Anegon I. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J. Immunol. 164:2000;5258.
23. Guinan E.C., Boussiotis V.A., Neuberg D., Brennan L.L., Hirano N., Nadler L.M., Gribben J.G. Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. 340:1999;1704.
24. Haberman B.H. Mechanical milk collection from mice for Bittner virus isolation. Lab. Anim. Sci. 24:1974;935.
25. Hayashi S., Guang-Lin M., Yokoyama I., Namii Y., Hamada H., Nakao A. Adenovirus-mediated gene transfer of CTLA4Ig gene results in prolonged survival of heart allograft. Transpl. Int. 13(Suppl. 1):2000;S329.
26. Hogan B., Beddington R., Costantini F., Lacy E. Production of transgenic mice. Manipulating the Mouse Embryo, A Laboratory Manual. 1994;219-251 Cold Spring Harbor Laboratory Press, New York, USA.
27. Kirk A.D., Harlan D.M., Armstrong N.N., Davis T.A., Dong Y., Gray G.S., Hong X., Thomas D., Fechner J.H.J., Knechtle S.J. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. U. S. A. 94:1997;8789.
28. Ko J.H., Lee C.S., Kim K.H., Pang M.G., Koo J.S., Fang N., Koo D.B., Oh K.B., Youn W.S., Zheng G.D., Park J.S., Kim S.J., Han Y.M., Choi I.Y., Lim J., Shin S.T., Jin S.W., Lee K.K., Yoo O.J. Production of biologically active human granulocyte colony stimulating factor in the milk of transgenic goat. Transgenic Res. 9:2000;215.
29. Krimpenfort P., Rademakers A., Eyestone W., van der Schans A., van den Broek S., Kooiman P., Kootwijk E., Platenburg G., Pieper F., Strijker R. Generation of transgenic dairy cattle using 'in vitro' embryo production. Biotechnology (N.Y.). 9:1991;844.
30. Kurlberg G., Haglind E., Schon K., Tornqvist H., Lycke N. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation. Scand. J. Immunol. 51:2000;224.
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
32. Lee C.S., Kim K., Yu D.Y., Lee K.K. An efficient expression of human growth hormone (hGH) in the milk of transgenic mice using rat beta-casein/hGH fusion genes. Appl. Biochem. Biotechnol. 56:1996;211-222.
33. Lenschow D.J., Zeng Y., Thistlethwaite J.R., Montag A., Brady W., Gibson M.G., Linsley P.S., Bluestone J.A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 257:1992;789.
34. Levisetti M.G., Padrid P.A., Szot G.L., Mittal N., Meehan S.M., Wardrip C.L., Gray G.S., Bruce D.S., Thistlethwaite J.R.J., Bluestone J.A. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J. Immunol. 159:1997;5187.
35. Limonta J.M., Castro F.O., Martinez R., Puentes P., Ramos B., Aguilar A., Lleonart R.L., de la Fuente J. Transgenic rabbits as bioreactors for the production of human growth hormone. J. Biotechnol. 40:1995;49.
36. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:1991;561.
37. Linsley P.S., Greene J.L., Brady W., Bajorath J., Ledbetter J.A., Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:1994;793.
38. Niemann H., Halter R., Carnwath J.W., Herrmann D., Lemme E., Paul D. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res. 8:1999;237.
39. Paleyanda R.K., Velander W.H., Lee T.K., Scandella D.H., Gwazdauskas F.C., Knight J.W., Hoyer L.W., Drohan W.N., Lubon H. Transgenic pigs produce functional human factor VIII in milk. Nat. Biotechnol. 15:1997;971.
40. Pearson T.C., Alexander D.Z., Winn K.J., Linsley P.S., Lowry R.P., Larsen C.P. Transplantation tolerance induced by CTLA4-Ig. Transplantation. 57:1994;1701.
41. Platenburg G.J., Kootwijk E.P., Kooiman P.M., Woloshuk S.L., Nuijens J.H., Krimpenfort P.J., Pieper F.R., de Boer H.A., Strijker R. Expression of human lactoferrin in milk of transgenic mice. Transgenic Res. 3:1994;99-108.
42. Prunkard D., Cottingham I., Garner I., Bruce S., Dalrymple M., Lasser G., Bishop P., Foster D. High-level expression of recombinant human fibrinogen in the milk of transgenic mice. Nat. Biotechnol. 14:1996;867-871.
43. Rodriguez A., Castro F.O., Aguilar A., Ramos B., Del Barco D.G., Lleonart R., De la Fuente J. Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits. Biol. Res. 28:1995;141-153.
44. Rokkones E., Fromm S.H., Kareem B.N., Klungland H., Olstad O.K., Hogset A., Iversen J., Bjoro K., Gautvik K.M. Human parathyroid hormone as a secretory peptide in milk of transgenic mice. J. Cell. Biochem. 59:1995;168-176.
45. Romano G., Michell P., Pacilio C., Giordano A. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells. 18:2000;19.
46. Schnieke A.E., Kind A.J., Ritchie W.A., Mycock K., Scott A.R., Ritchie M., Wilmut I., Colman A., Campbell K.H. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science. 278:1997;2130.
47. Sebille F., Vanhove B., Soulillou J.P. Mechanisms of tolerance induction: blockade of co-stimulation. Philos. Trans. R. Soc. Lond., B Biol. Sci. 356:2001;649.
48. Shani M., Barash I., Nathan M., Ricca G., Searfoss G.H., Dekel I., Faerman A., Givol D., Hurwitz D.R. Expression of human serum albumin in the milk of transgenic mice. Transgenic Res. 1:1992;195-208.
49. Simons J.P., McClenaghan M., Clark A.J. Alteration of the quality of milk by expression of sheep beta-lactoglobulin in transgenic mice. Nature. 328:1987;530.
50. Sohn B.H., Kim S.J., Park H., Park S.K., Lee S.C., Hong H.J., Park Y.S., Lee K.K. Expression and characterization of bioactive human thrombopoietin in the milk of transgenic mice. DNA Cell Biol. 18:1999;845-852.
51. Thepot D., Devinoy E., Fontaine M.L., Stinnakre M.G., Massoud M., Kann G., Houdebine L.M. Rabbit whey acidic protein gene upstream region controls high-level expression of bovine growth hormone in the mammary gland of transgenic mice. Mol. Reprod. Dev. 42:1995;261.
52. Toman P.D., Pieper F., Sakai N., Karatzas C., Platenburg E., de Wit I., Samuel C., Dekker A., Daniels G.A., Berg R.A., Platenburg G.J. Production of recombinant human type I procollagen homotrimer in the mammary gland of transgenic mice. Transgenic Res. 8:1999;415-427.
53. Tomasoni S., Azzollini N., Casiraghi F., Capogrossi M.C., Remuzzi G., Benigni A. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J. Am. Soc. Nephrol. 11:2000;747.
54. Turka L.A., Linsley P.S., Lin H., Brady W., Leiden J.M., Wei R.Q., Gibson M.L., Zheng X.G., Myrdal S., Gordon D. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11102.
55. Uusi-Oukari M., Hyttinen J.M., Korhonen V.P., Vasti A., Alhonen L., Janne O.A., Janne J. Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice. Transgenic Res. 6:1997;75-84.
56. van Berkel P.H., Welling M.M., Geerts M., van Veen H.A., Ravensbergen B., Salaheddine M., Pauwels E.K., Pieper F., Nuijens J.H., Nibbering P.H. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat. Biotechnol. 20:2002;484.
57. Van Cott K.E., Williams B., Velander W.H., Gwazdauskas F., Lee T., Lubon H., Drohan W.N. Affinity purification of biologically active and inactive forms of recombinant human protein C produced in porcine mammary gland. J. Mol. Recognit. 9:1996;407.
58. Vaughan A.N., Malde P., Rogers N.J., Jackson I.M., Lechler R.I., Dorling A. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7. J. Immunol. 165:2000;3175.
59. Velander W.H., Johnson J.L., Page R.L., Russell C.G., Subramanian A., Wilkins T.D., Gwazdauskas F.C., Pittius C., Drohan W.N. High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proc. Natl. Acad. Sci. U. S. A. 89:1992;12003.
60. Whitelaw C.B., Harris S., McClenaghan M., Simons J.P., Clark A.J. Position-independent expression of the ovine beta-lactoglobulin gene in transgenic mice. Biochem. J. 286(Pt 1):1992;31.
61. Wolf E., Jehle P.M., Weber M.M., Sauerwein H., Daxenberger A., Breier B.H., Besenfelder U., Frenyo L., Brem G. Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins. Endocrinology. 138:1997;307.
62. Wright G., Carver A., Cottom D., Reeves D., Scott A., Simons P., Wilmut I., Garner I., Colman A. High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Biotechnology (N.Y.). 9:1991;830.